Carbonic anhydrase inhibitors (CAIs) have been used for many decades in the treatment of
glaucoma. Systemic CAIs were an early treatment option to lower intraocular pressure by …

Glaucoma a debilitating disease, is globally the second most common kind of permanent
blindness. Primary open-angle glaucoma (POAG) is its most prevalent form and is often …

Obstructive sleep apnea (OSA) is a sleep disorder characterized by intermittent complete or
partial occlusion of the airway. Despite a recognized association between OSA and …

The aim of this work is to survey the potential of cubogel as an ocular dosage form to boost
the corneal permeability of Dorzolamide Hydrochloride DZ; an antiglaucomal drug. DZ …

The translaminar pressure gradient (TLPG) refers to two forces at the lamina cribosa of the
optic nerve: the anteriorly acting intracranial pressure (ICP), and posteriorly-acting …

Glaucoma of which primary open angle glaucoma (POAG) constitutes 75%, is the second
leading cause of blindness. Elevated intra ocular pressure and Nitric oxide synthase (NOS) …

Introduction Glaucoma is the leading cause of irreversible blindness worldwide. Medical
therapy is the main line of treatment of open-angle glaucoma (OAG) and ocular …

Melatonin is of great importance for regulating several eye processes, including pressure
homeostasis. Melatonin in combination with agomelatine has been recently reported to …

The key clinical attributes of preserved dorzolamide/timolol fixed combination (DTFC) and
the emerging potential of preservative-free (PF) DTFC are reviewed with published evidence …

Purpose To assess the safety and efficacy of a ciliary neurotrophic factor (CNTF) intraocular
implant on neuroprotection and neuroenhancement in glaucoma. Design Open-label …